The Philippines is the third-largest pharmaceutical market in ASEAN after Thailand and Indonesia. In 2019, total generic drug sales were in the Philippines were PHP82.3 billion, and accounts for 63% of prescription sales and estimate to reach PHP110 Billion by 2024. The highest cost of medicines in the Philippines among other ASEAN countries is one […]

Read More →

The Philippines is a country with a large population and a wide network of hospitals, medical centers, and healthcare professionals, making it a fertile platform for conducting clinical trials. In clinical trials, the Philippines ranks number three in Southeast countries (US NIH) and ranks number eight worldwide (European Medicines Agency reports). Clinical trial statistics in […]

Read More →